Exposure to particulate matter (PM) can trigger cardiovascular morbidity and mortality after long-term exposure (years) and short-term exposures (hours to days) ([@r7]; [@r8]; [@r32]; [@r47]). Possible physiological pathways for cardiovascular effects of air pollution exposure are systemic inflammation, blood coagulation, and changes in the autonomic nervous system ([@r7]). These mechanisms may eventually lead to myocardial infarctions and arrhythmias, which could lead to hospitalization and mortality ([@r3]; [@r7]; [@r13]). Traffic-related air pollution has been suggested to play an important role ([@r12]). Evidence for associations between ambient air pollutants and physiological markers of systemic inflammation and blood coagulation has been obtained in controlled chamber exposure studies and epidemiological studies ([@r7]). Epidemiological studies have typically assessed the association between ambient air pollution concentrations averaged over the previous 24--72 hr and markers of systemic inflammation and coagulation ([@r10]; [@r20]; [@r31]; [@r34]; [@r44]; [@r48]). There is much less information about effects of short (1--2 hr), transient, peak exposures encountered during commuting.

Myocardial infarction was associated with increased participation in traffic in the hours before the onset of the myocardial infarction in a case-crossover study ([@r35]). The effect was hypothesized to be caused by air pollution exposure in traffic, although alternative explanations such as stress and traffic noise could not be ruled out. Some controlled exposure chamber studies found acute effects of 200--300 µg/m³ diesel exhaust on blood inflammation markers ([@r27]; [@r42]) or coagulation markers ([@r26]), but the evidence remains inconsistent ([@r4]; [@r9]; [@r18]; [@r28]; [@r30]).

Only a few studies have examined personal, real-life, traffic-related air pollution exposure in relation to acute changes in cardiovascular markers. [@r37]found associations of measured in-vehicle air pollution concentrations with inflammation and coagulation markers in patrol troopers exposed during their approximately 8-hr work shifts. [@r1] found a relation between measured in-bus air pollution exposure of a group of elderly subjects and heart rate variability. [@r23] found no associations between exposure during 30 min of cycling in traffic and inflammation and coagulation markers, except for a small increase in neutrophils as a percentage of leukocytes.

The Transport-Related Air Pollution, Variance in Commuting, Exposure and Lung Function (TRAVEL) study was designed to examine exposure of commuters to air pollution and associated respiratory and cardiovascular health effects. Details on air pollution exposures encountered during commuting and the related respiratory health effects have been published previously ([@r49], [@r50]). The aim of this study was to assess the acute effects of in-traffic air pollution exposure on several cardiovascular biomarkers.

Methods
=======

*Study design.* We measured exposure to particle number (PN), particulate matter (PM) ≤ 2.5 µm (PM~2.5~) and ≤ 10 µm (PM~10~) in aerodynamic diameter, and soot during predefined 2-hr morning commutes of 34 healthy, nonsmoking volunteers in cars, buses, and on bicycles. Volunteers were selected through intranet web sites of their employers. The inclusion criteria were age between 18 and 56 years and nonsmoking. We took measurements between 0800 and 1000 hours on 47 weekdays during June 2007 through June 2008. Exposure contrasts derived from day-to-day variation and differences in commuting mode on each sampling day. We collected blood samples before exposure and 6 hr after traffic exposure at the same times each day to keep circadian variation constant; air pollution exposure varied from day to day. We selected blood parameters and time points after reviewing previous studies of ambient and controlled exposures ([@r19]; [@r29], [@r28], [@r27]; [@r30]; [@r31]; [@r33], [@r34], [@r35]; [@r37]; [@r42]; [@r44]). Because we studied a range of respiratory, inflammatory, and coagulation markers, we selected a time point for measuring outcomes that was a compromise among the time points at which the individual markers were expected to be most likely to change in response to exposure. Specifically, we collected blood 6 hr after exposure because of *a*) reported increases in neutrophils and platelets in blood 6 hr after a 1-hr experimental exposure of healthy volunteers to fresh diesel exhaust ([@r42]); *b*) an increase in platelets 2 hr after exposure to concentrated ambient fine and ultrafine particles ([@r27]); *c*) an increase in platelet activation and thrombus formation 6 hr after exposure to diesel exhaust ([@r26]); and *d*) an increase in C-reactive protein (CRP) immediately after and 4 hr after exposure of healthy volunteers and volunteers with asthma to concentrated ambient ultrafine particles ([@r18]). In addition, two epidemiological studies by Peters et al. found an association between onset of myocardial infarction and exposure to traffic ([@r35]) and PM~2.5~ ([@r33]) 2--4 hr before the myocardial infarction. Furthermore, several studies documented significant airway inflammation at that time point ([@r42]; [@r45]) or at 4 hr postexposure ([@r30]). An important mechanism for systemic inflammation is prior airway inflammation.

We measured exposures during morning rush hour when they were expected to be highest and because exposures would be minimized immediately before the experiment. We selected subjects living close (\< 20 min) to the starting point of exposure to limit prior exposures and selected office workers to limit exposures between commuting and the health evaluation 6 hr after exposure. We excluded participants who were exposed to fumes or dust at work.

*Commuting modes. S*ampling days were divided among cycling sampling days (which included two different cycling routes that varied in traffic intensity), car sampling days (including diesel and gasoline-powered cars), and bus sampling days (including both electric trolley buses and diesel buses). All measurements were performed in Arnhem, a medium- sized Dutch city (145,000 inhabitants). On cycling sampling days, technicians rode three-wheeled cargo bicycles to transport the equipment; on car sampling days the cars were driven by the technicians. On each sampling day, three or four volunteers rode in each type of car, bus, or cycle route. The volunteers were scheduled to participate in all commuting modes for a maximum of 12 times.

*Exposure assessment.* The exposure assessment has been reported in detail previously ([@r49]). We measured PN concentrations using condensation particle counters (CPC; model 3007; TSI Inc., Shoreview, MN, USA). We measured PM~2.5~ with active sampling personal DataRAMs (model 1200; MIE Inc., Bedford, MA, USA). Both CPCs and DataRAMs measured real-time concentrations, recording every second. We collected PM~10~ using Harvard Impactors (Air Diagnostics and Engineering Inc., Naples, ME, USA). We determined soot content of the filters using a smoke stain reflectometer (model M43D; Diffusion Systems Ltd., London, UK) and converted the values into an absorption coefficient. For estimations of elemental carbon (EC) inhaled doses, we converted absorption (soot) levels into EC concentrations using the equation EC (micrograms per cubic meter) = 1.6053 × absorption (10^--5^per meter) -- 0.2620 ([@r11]). Hourly ambient nitrogen dioxide (NO~2~), ozone (O~3~), and PM~10~ concentrations measured with chemiluminescence, ultraviolet absorption, and beta attenuation continuous monitors were obtained from the Dutch National Air Quality Monitoring Network \[for additional details, see Supplemental Material, p. 2 (<http://dx.doi.org/10.1289/ehp.1003151>)\].

In addition to measuring exposures to air pollutants, we estimated doses of inhaled air pollutants to account for differences in ventilation during cycling compared with commuting by car or bus. Specifically, we estimated minute ventilation levels for all individuals during all trips, based on their heart rate measurements during commuting (measured using Polar RS400 heart rate monitors; Polar Electro, Kempele, Finland) and previously determined information for each individual participant on the relation between their heart rate and minute ventilation ([@r51]). Inhaled doses were calculated by multiplying concentrations, minute ventilation, and duration of the trip, divided by body surface area (BSA) to correct for differences in airway epithelial surface area. We calculated BSA using the equation
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*Clinical measurements.* We collected venous blood before exposure and 6 hr after the end of exposure. Samples were transported to a local hospital laboratory within 1 hr of blood sampling and immediately processed. Blood cell counts were performed immediately. For all other analyses, plasma was stored at --80°C, and all samples were analyzed at the same time after the fieldwork period ended. The study was approved by the medical ethical committee of Utrecht University Medical Centre. All participants gave written informed consent prior to the study.

Inflammation markers. We analyzed CRP using a CRP Vario high-sensitivity assay (Architect, Abbott Diagnostics, Hoofddorp, the Netherlands). Interleukin (IL) 6, IL8, IL10, and tumor-necrosis factor α (TNFα) were analyzed in duplicate, using a Luminex assay ([@r21]). We used mean values in analyses.

Marker of lung epithelial damage. We analyzed Clara cell protein 16 (CC16) using a sandwich enzyme immunoassay (CC16 ELISA kit; DiaMed EuroGen, Turnhout, Belgium) as described by the manufacturer.

Blood cell number counts. We performed analyses on white and red blood cell counts and platelets using the automated XE-2100 hematology analyzer (Sysmex Nederland B.V., Etten-Leur, Netherlands).

Blood coagulation markers. We analyzed prothrombin time (PT), activated partial thromboplastin time (APTT), platelets, fibrinogen, factor VII, and von Willebrand factor (vWF) using the STA-R automated coagulation analyzer (Diagnostica Stago, Asnières-sur-Seine, France),

*Statistical analyses.* We used mixed models to analyze relations between variation in either the measured exposures or estimated inhaled doses of each individual air pollutant (PN, PM~2.5~, PM~10~, or EC, in separate models) and the blood parameters. We used repeated measurement analyses to correct for correlation between measurements of the same subject, and we included random intercepts for subjects to account for individual differences.

Changes in biomarkers between postexposure and preexposure measurements were used as dependent variables. We used log transformations of postexposure and preexposure measurements when the distribution of the residuals of post exposure -- pre exposure differences were right-skewed. This was the case for CRP, IL6, IL8, IL10, and TNFα. Relatively large numbers of samples were below the detection limit and at the lower end of the calibration curve for IL6, IL8, IL10, and TNFα \[see Supplemental Material, p. 4 (<http://dx.doi.org/10.1289/ehp.1003151>)\]; therefore, we also performed logistic regression analyses for these markers, dichotomizing them at the 80th percentiles of the preexposure to postexposure changes.

The magnitude of change in health outcomes was calculated for interquartile range (IQR) increases in exposures or estimated doses. Potential confounders included in models for all end points were relative humidity and temperature (2-hr means, measured during commuting), season (spring, autumn, and winter; there were no measurements in summer), and minutes of traffic participation before baseline measurements and separately for time in traffic between 1000 and 1600 hours. We also included a variable indicating whether commuting was by bicycle or by car/bus in the model, because we observed an independent effect of cycling on several markers in blood. Mean ambient background NO~2~ concentrations during the 24 hr before commuting exposure were included to account for potential effects of ambient air pollution on pre- and postcommuting outcome measurements. Sensitivity analyses were performed using ambient PM~10~ or ambient O~3~ instead of ambient NO~2~ and by excluding observations with cough at baseline as a marker of a cold. Effect modification was analyzed using stratified analyses for cycling versus riding by car/bus, body mass index (BMI; categorized as below or above 25 kg/m²), and fruit and vitamin intake (the high category defined as seven or more fruits per week or taking vitamin supplements on ≥ 5 days/week). To assess the influence of outliers on regressions, we performed additional analyses leaving out 1% (maximum of four) of observations with the highest Cook's distance values. Level of significance was defined as a *p*-value of 0.05. Data were analyzed using SAS 9.2 (SAS Institute Inc., Cary, NC, USA).

Results
=======

*Exposure.* We performed measurements on 16 bicycle-sampling days, 16 car-sampling days, and 15 bus-sampling days. Exposures to and inhaled doses of all pollutants varied widely between days ([Figure 1](#f1){ref-type="fig"}). PM~2.5~ concentrations were likely overestimated because of the photometrical instrument used ([@r49]), but the differences in exposures between measurement days are likely to be valid measures of the actual differences. Because of their increased physical activity, the estimated minute ventilation of cyclists was higher than that of car and bus passengers. Estimated minute ventilations of cyclists were 23.5 L/min, on average, compared with 11.8 for car passengers and 12.7 L/min for bus passengers ([@r51]).

![Air pollutant exposures (*A*) and inhaled doses (*B*) in transport. In *A*,*n* = 93, with two commuting modes on 47 sampling days and one mode missing. PM~2.5~ was measured photometrically, whereas PM~10~ was measured gravimetrically. Photometric instruments can overestimate exposures; therefore, PM~2.5~ is high compared with PM~10~. In *B*, *n* = 345, with 34 volunteers participating 5--12 times; doses were adjusted for BSA.](ehp.1003151.g001){#f1}

In-traffic exposures were substantially higher than were urban background concentrations measured during rush hour (e.g., for soot, 2.0--3.7 times higher; for PN, 1.6--2.5 times higher) ([@r49]). Ambient NO~2~ and O~3~ exposure levels of the 24 hr preceding the start of exposure ranged from 15 to 66 µg/m³ (mean, 32 µg/m³) and from 4 to 141 µg/m³ (mean, 56 µg/m³), respectively. Ambient PM~10~ of the preceding day ranged from 13 to 55 µg/m³ (mean, 28 µg/m³).

Spearman correlation coefficients were 0.58, 0.32, and 0.45 between soot and PN, PM~2.5~, and PM~10~ exposures, respectively, and 0.38 between PM~2.5~ and PM~10~ exposures (*p* \< 0.01 for all). PN exposure was not correlated with PM~2.5~ or PM~10~ exposures. Estimated doses were correlated among all of the pollutants, with coefficients ranging from 0.34 (for PN and PM~2.5~ doses) to 0.74 (for PN and EC doses) (*p* \< 0.01 for all).

*Clinical measurements.* Characteristics of the 34 participants are given in [Table 1](#t1){ref-type="table"}. In total, 352 individual health outcome measurements were conducted on 47 sampling days (pre- and postexposure). Each subject participated on at least 5 days, with a maximum of 12 days.

###### 

Descriptive characteristics of the subjects (*n* = 34).

  Characteristic                                                                                                                                                               Mean (range) or *n* (%)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------
  Age (years)                                                                                                                                                                  42.0 (23--55)
  BMI (kg/m²^)^                                                                                                                                                                
  \< 25                                                                                                                                                                        19 (56)
  ≥ 25                                                                                                                                                                         15 (44)
  BSA (m²)*a*                                                                                                                                                                  2.0 (1.5--2.3)
  Sex                                                                                                                                                                          
  Male                                                                                                                                                                         24 (71)
  Female                                                                                                                                                                       10 (29)
  Ex-smokers                                                                                                                                                                   10 (29)
  Fruit and vitamin intake*b*                                                                                                                                                  
  High*c*                                                                                                                                                                      20 (59)
  Low                                                                                                                                                                          13 (38)
  **a**BSA = √ [(length × weight)]{.ul}/3,600. **b**Data were missing for one person. **c**Diet included ≥ 7 fruits per week or taking vitamin supplements on ≥ 5 days/week.   

By specifying random intercepts, we assured assessment of associations between temporal within-person variability of biological markers and air pollution exposure. Mean baseline levels and mean post exposure -- preexposure differences of the biomarkers are reported in Supplemental Material, [Table 1](#t1){ref-type="table"} (<http://dx.doi.org/10.1289/ehp.1003151>).

*Associations between air pollution and blood inflammation markers.* We did not find consistent associations of air pollution with changes in IL6, IL8, TNFα, CRP, or CC16 ([Table 2](#t2){ref-type="table"}). An IQR increase in mean PM~2.5~ exposure was associated with a 5.4% decrease in IL10 \[95% confidence interval (CI), --11 to --0.2; *p* = 0.04\], contrary to expectations. PN dose was associated with a 14% decrease in TNFα (95% CI, --31 to 2.6; *p* = 0.10). Consistent with our hypothesis, PN dose was positively associated with CRP (1.8%; 95% CI, --0.1 to 3.8; *p* = 0.07) and PN exposure with IL8 (17%; 95% CI, --0.9 to 34; *p* = 0.06). The logistic regression produced no significant associations between air pollution and inflammation markers (data not shown). Estimates that were not adjusted for potential confounders were comparable with the adjusted estimates (data not shown). The confounding effect of cycling was a significant predictor of IL10 and TNFα. In stratified analysis, IL10 was associated with soot exposure during car/bus trips (5.0%; 95% CI, --0.5 to 11; *p* = 0.08) but not bicycle trips (--0.6%; 95% CI, --16 to 14; *p* = 0.94), but differences between strata were not significant \[see Supplemental Material, [Table 3](#t3){ref-type="table"}, (<http://dx.doi.org/10.1289/ehp.1003151>)\]. We observed no significant differences with TNFα between bicycle trips and car/bus trips. An analysis excluding the 26 observations with cough reported at baseline as a marker of a cold did not change the results.

###### 

Effect estimates \[% (95% CI)\] for differences in markers of inflammation and lung epithelial damage per IQR change in exposure and inhaled dose.

  Dose/exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     IL6   IL8                   IL10   TNFα                  CRP   CC16                                                                               
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----- --------------------- ------ --------------------- ----- --------------------------- -- ---------------------- -- ---------------------- -- ----------------------
  PN dose                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 --0.8 (--14 to 13)           5.9 (--8.4 to 20)           0.3 (--4.7 to 5.4)             --14 (--31 to 2.6)\*      1.8 (--0.1 to 3.8)\*      0.2 (--2.7 to 3.0)
  PN exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             --14 (--30 to 3.1)           17 (--0.9 to 34)\*          --1.2 (--7.2 to 4.8)           --16 (--37 to 6.3)        0.0 (--2.5 to 2.4)        --1.6 (--4.7 to 1.6)
  PM~2.5~ dose                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            --2.6 (--13 to 8.0)          --3.0 (--14 to 8.2)         --2.8 (--6.5 to 1.0)           --1.8 (--16 to 12.1)      --0.6 (--2.2 to 0.9)      --1.3 (--3.4 to 0.8)
  PM~2.5~ exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        --1.3 (--15 to 13)           --8.3 (--24 to 7.0)         --5.4 (--11 to --0.2)\*\*      --0.6 (--20 to 19)        --1.6 (--3.8 to 0.5)      --1.8 (--4.5 to 1.0)
  PM~10~ dose                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             --3.1 (--18 to 12)           --3.9 (20 to 12)            1.0 (--4.5 to 6.5)             --5.7 (--24 to 12)        0.1 (--2.1 to 2.3)        --2.0 (--5.0 to 1.0)
  PM~10~ exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         --3.1 (--15 to 8.5)          --0.4 (--2.9 to 12)         --0.4 (--4.7 to 3.8)           --1.9 (--17 to 13)        --0.7 (--2.5 to 1.0)      --1.4 (--3.6 to 0.8)
  Soot dose (EC)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          --0.2 (--11 to 10)           3.2 (--8.2 to 15)           1.4 (--2.5 to 5.3)             --8.9 (--22 to 4.7)       0.9 (--0.7 to 2.5)        --0.9 (--3.0 to 1.2)
  Soot exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           --3.5 (--15 to 8.2)          3.4 (--9.5 to 16)           0.8 (--3.6 to 5.2)             --7.4 (--23 to 8.7)       0.0 (--1.8 to 1.8)        --1.9 (--4.1 to 0.4)
  Log-transformed values were used for CRP, IL6, IL8, IL10, and TNFα; for CC16, percent change was calculated as estimate divided by the mean baseline value. Estimates were calculated using mixed-model analyses per IQR change (95% CI). IQRs of 2-hr mean values were as follows: PN, 18,195 pt/cm³ (exposure) and 2.40 × 10^10^ pt/m^2^ (dose); PM~2.5~, 68.1 µg/m³ (exposure) and 61.9 µg/m² (dose); PM~10~, 20.8 µg/m³ (exposure) and 32.4 µg/m² (dose); soot, 3.51 × 10^--5^/m (exposure) and 6.31 µg/m² (EC dose, calculated from soot absorption). Doses were adjusted for BSA; exposures were adjusted for relative humidity, temperature, season, time test was taken, ambient NO~2~, cycling, and time privately spent in traffic before 0800 hours and between 1000 and 1600 hours. \**p* \< 0.10. \*\**p* \< 0.05.                                                                                                                                                     

###### 

Effect estimates \[% (95% CI)\] for differences in blood cell counts per IQR change in exposure and inhaled dose.

  Dose/exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Erythrocytes (%)   Leukocytes (%)         Neutrophils (%)   Lymphocytes (%)                                           
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ---------------------- ----------------- ---------------------- -- ---------------------------- -- ----------------------
  PN dose                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     0.1 (--0.3 to 0.4)                       --0.5 (--2.3 to 1.4)      --2.0 (--5.4 to 1.5)            0.1 (--2.1 to 2.3)
  PN exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 --0.1 (--0.5 to 0.4)                     --1.6 (--3.8 to 0.6)      --3.8 (--7.6 to 0.0)\*          0.7 (--1.8 to 3.3)
  PM~2.5~ dose                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                --0.2 (--0.5 to 0.1)                     --0.8 (--2.2 to 0.5)      --2.5 (--5.0 to --0.1)\*\*      0.7 (--0.8 to 2.3)
  PM~2.5~ exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            --0.3 (--0.7 to 0.1)                     --0.7 (--2.6 to 1.2)      --2.4 (--5.7 to 0.8)            1.3 (--0.9 to 3.4)
  PM~10~ dose                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 --0.1 (--0.6 to 0.2)                     --0.1 (--2.2 to 1.9)      --0.1 (--3.7 to 3.5)            --1.3 (--3.7 to 1.0)
  PM~10~ exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             --0.2 (--0.5 to 0.1)                     --0.7 (--2.2 to 0.9)      --0.7 (--3.4 to 1.9)            --0.9 (--2.6 to 0.9)
  Soot dose (EC)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              0.1 (--0.1 to 0.4)                       --0.7 (--2.2 to 0.7)      --1.5 (--4.1 to 1.1)            --0.3 (--2.0 to 1.3)
  Soot exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               0.1 (--0.2 to 0.4)                       --0.9 (--2.5 to 0.7)      --1.6 (--4.4 to 1.2)            0.0 (--1.8 to 1.8)
  Change was calculated as the estimate divided by the mean baseline value. Estimates were calculated using mixed-model analyses per IQR change (95% CI). IQRs of 2-hr mean values were as follows: PN, 18,195 pt/cm³ (exposure) and 2.40 × 10^10^ pt/m^2^ (dose); PM~2.5~, 68.1 µg/m³ (exposure) and 61.9 µg/m² (dose); PM~10~, 20.8 µg/m³ (exposure) and 32.4 µg/m² (dose); soot 3.51 × 10^--5^/m (exposure) and 6.31 µg/m² (EC dose, calculated from soot absorption). Doses were adjusted for BSA; exposures were adjusted for relative humidity, temperature, season, time test was taken, ambient NO~2~, cycling, and time privately spent in traffic before 0800 and between 1000 and 1600 hours. \**p* \< 0.10. \*\**p* \< 0.05.                                                                                                                         

*Associations between air pollution and blood cell counts.* We found no associations between IQR increases in mean air pollution levels and erythrocytes, lymphocytes ([Table 3](#t3){ref-type="table"}), basophils, eosinophils, and monocytes \[Supplemental Material, [Table 4](#t4){ref-type="table"}, (<http://dx.doi.org/10.1289/ehp.1003151>)\]. There were consistent but nonsignificant negative associations of all pollutants and leukocytes (--0.1 to --1.6%), and of PN and PM~2.5~ and neutrophils (--2.0 to --3.8%) ([Table 3](#t3){ref-type="table"}); these associations were opposite from our hypothesis. The associations between PN exposure and dose and neutrophils became significant and stronger after removal of four influential data points with highest Cook's distance values (data not shown). Stratified analyses showed stronger negative associations with leukocyte and neutrophil counts in cycling trips than in car/bus trips of PN, PM~2.5~, and soot (not PM~10~). Mean PN exposure during cycling trips was associated with increases of 4.9 and 11% (*p* = 0.08 and *p* = 0.04) in leukocytes and neutrophils, respectively, whereas associations were 1.0 and 0.4% (*p* = 0.48 and *p* = 0.85) for car/bus trips (see Supplemental Material, Table 5).

###### 

Effect estimates \[% (95% CI)\] for differences in coagulation markers per IQR change in exposure and inhaled dose.

  Dose/exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              APTT (%)   PT (%)                     vWF (%)   Factor VII (%)       Platelets (%)   Fibrinogen (%)                                                                        
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------- -------------------------- --------- -------------------- --------------- ---------------------- -- ---------------------------- -- ------------------------ -- ----------------------
  PN dose                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               0.0 (--0.4 to 0.3)                   0.3 (--0.1 to 0.7)                   0.4 (--0.7 to 1.5)        --0.5 (--1.4 to 0.3)            --0.1 (--0.9 to 0.6)        --0.1 (--0.9 to 0.8)
  PN exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           0.0 (--0.4 to 0.4)                   0.4 (--0.1 to 0.9)                   --0.8 (--2.0 to 0.4)      --1.5 (--2.5 to --0.5)^\#^      0.0 (--0.9 to 0.9)          0.2 (--0.9 to 1.2)
  PM~2.5~ dose                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          --0.1 (--0.4 to 0.1)                 0.3 (0.0 to 0.6)\*                   --0.2 (--1.0 to 0.6)      0.3 (--0.3 to 0.9)              0.1 (--0.5 to 0.6)          0.1 (--0.6 to 0.8)
  PM~2.5~ exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      --0.3 (--0.7 to 0.0)\*\*             0.0 (--0.4 to 0.4)                   0.0 (--1.0 to 1.1)        0.4 (--0.5 to 1.2)              --0.1 (--0.8 to 0.7)        --0.1 (--1.0 to 0.8)
  PM~10~ dose                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           --0.2 (--0.5 to 0.2)                 0.3 (--0.2 to 0.7)                   0.4 (--0.8 to 1.5)        0.1 (--0.8 to 1.0)              --0.7 (--1.5 to 0.2)        0.1 (--0.8 to 1.0)
  PM~10~ exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       --0.3 (--0.5 to 0.0)\*               0.1 (--0.3 to 0.4)                   0.1 (--0.8 to 1.0)        0.0 (--0.7,0.7)                 --0.6 (--1.2 to 0.1)\*      --0.1 (--0.8 to 0.7)
  Soot dose (EC)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        --0.1 (--0.3 to 0.2)                 0.1 (--0.2 to 0.4)                   0.2 (--0.6 to 1.0)        --0.2 (--0.8 to 0.5)            --0.2 (--0.8 to 0.3)        0.2 (--0.5 to 0.9)
  Soot exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         --0.1 (--0.4 to 0.2)                 0.0 (--0.4 to 0.3)                   0.1 (--0.8 to 1.0)        --0.3 (--1.0 to 0.4)            --0.3 (--0.9 to 0.4)        0.5 (--0.2 to 1.3)
  Change was calculated as the estimate divided by the mean baseline value. Estimates were calculated using mixed-model analyses per IQR change (95% CI). IQRs of 2-hr mean values were as follows: PN. 18,195 pt/cm³ (exposure) and 2.40 × 10^10^ pt/m^2^ (dose); PM~2.5~, 68.1 µg/m³ (exposure) and 61.9 µg/m² (dose); PM~10~, 20.8 µg/m³ (exposure) and 32.4 µg/m² (dose); soot, 3.51 × 10^--5^/m (exposure) and 6.31 µg/m² (EC dose, calculated from soot absorption). Doses were adjusted for BSA. Exposures were adjusted for relative humidity, temperature, season, time test was taken, ambient NO~2~, cycling, and time privately spent in traffic before 0800 and between 1000 and 1600 hours. \**p* \< 0.10. \*\**p* \< 0.05. ^\#^*p* \< 0.01.                                                                                                                                                                              

*Associations between air pollution and blood coagulation markers.* We found associations between IQR increases in mean PM~2.5~ and PM~10~ exposure and a decrease in APTT ([Table 4](#t4){ref-type="table"}). However, PT tended to increase with increasing air pollution exposures. PN exposure was associated with a significant 1.5% decrease in factor VII, contrary to the hypothesized direction. We found no associations of air pollution with vWF, platelets, and fibrinogen. Stratified analyses showed that in car/bus trips, PM~2.5~ and PM~10~ were associated with a shorter APTT, but in cyclists they were associated with longer APTT, which was not consistent with expectations. For example, associations with APTT in cyclists with PM~2.5~ and PM~10~ exposure were 1.1% (0.2 to 2.0; *p* = 0.01) and 0.9% (0.1 to 1.7; *p* = 0.03), respectively, whereas in cars they were --0.6% (--1.0 to --0.2; *p* \< 0.01) and --0.4% (--0.7 to --0.1; *p* = 0.02) \[see Supplemental Material, Table 6, (<http://dx.doi.org/10.1289/ehp.1003151>)\].

*Additional analyses.* Associations with cell counts, blood coagulation, and inflammation markers were similar when including ambient PM~10~ or O~3~ in the model instead of NO~2~ (data not shown). An analysis of the postexposure measurements instead of the post exposure -- preexposure differences also did not show any consistent associations between in-traffic exposure and blood markers (data not shown). We found no significant differences after stratification into high or low BMI or high or low fruit and vitamin intake groups (data not shown). Associations between IQR increases in PN and the outcomes were similar when median and 95th percentile values were analyzed instead of mean values (data not shown).

Discussion
==========

Air pollution exposure during commuting was not associated with consistent changes in inflammation markers, blood cell counts, or coagulation markers in this study.

Several biological mechanisms have been proposed for the short-term effect of air pollution on cardiovascular events ([@r7]). One of the mechanisms involves airway inflammation and oxidative stress resulting in systemic inflammation, indicated by increases in cytokine levels and increases in neutrophils and other white blood cells. A second mechanism involves translocation of particles directly in the blood, resulting in systemic inflammation. Systemic inflammation may result in an acute-phase response indicated by increases in CRP and fibrinogen. Inflammation may also directly increase coagulation and thrombosis, as well as endothelial function. A third mechanism involves effects on the autonomic nervous system reflected in changes in, for example, heart rate variability. In the present study we assessed systemic inflammation including cytokines and white blood cell counts and the further potential consequences of (especially) inflammation for markers of coagulation and thrombosis.

*Blood inflammation and lung epithelium.* We found no consistent associations between air pollution exposures and inhaled doses and the inflammation markers IL6, IL8, IL10, TNFα, and CRP and the lung epithelium marker CC16 6 hr after exposure. The single study on in-traffic exposures that evaluated systemic inflammation markers found associations between in-vehicle exposure and blood levels of CRP 14 hr after exposure ([@r37]). Controlled exposure studies of acute effects of 1- to 2-hr exposure to diesel exhaust did not find acute effects on inflammation markers ([@r9]; [@r26]; [@r28]; [@r30]) or CC16 ([@r6]). The relatively large number of samples with undetectable IL6, IL8, IL10, and TNFα reduced the power of the analyses for these markers, as is evident from the larger CIs for the inflammation markers compared with the other biomarkers.

*Blood cell counts.* Although overall there was little association with blood cell counts, exposure in traffic was associated with a small decrease in leukocytes and neutrophils, contrary to the hypothesized direction. Two previous studies found increases in neutrophils 6 hr after 1-hr exposure to diesel exhaust ([@r42]) or 14 hr after 9-hr in-vehicle exposure ([@r37]). [@r23] found an increase in neutrophils as a percentage of leukocytes after 30-min exposure during cycling in traffic but no changes in absolute counts of neutrophils or leukocytes. Most studies did not find evidence of effects on leukocytes or neutrophils after exposures to diesel exhaust ([@r25]; [@r26]; [@r29], [@r28]), concentrated ambient air ([@r19]), concentrated carbon particles ([@r38]), or ultrafine particles ([@r18]). Two studies found a decrease in leukocytes after ambient exposure to PN and PM~2.5~ ([@r41]) and exposure to concentrated ambient air ([@r16]). The small decrease in neutrophils and leukocytes in the present study could be a chance finding. Alternatively, a decrease could be explained by neutrophils moving out of the bloodstream into the stressed tissue (e.g., the lungs).

*Blood coagulation markers.* We found inverse associations between PM~10~ and PM~2.5~ dose and APTT, consistent with expectations, but the positive associations observed between PT and air pollution were contrary to our hypothesis. The discrepancy between the APTT and PT findings is biologically difficult to explain. The lack of association with other markers further argues against a causal interpretation of the associations. Some studies have reported associations between air pollution exposures and vWF, fibrinogen, and platelets ([@r17]; [@r27]; [@r37]; [@r42]). Other previous studies reported no associations between exposures and platelets, fibrinogen, vWF, and factor VII ([@r4]; [@r5]; [@r9]; [@r19], [@r18]; [@r26]; [@r29], [@r28], [@r27]; [@r38]; [@r43]). The inverse association between PN exposure and factor VII may be due to chance, but it is supported by findings of [@r40] and [@r44], who found decreases in factor VII with a 1- to 3-day lag in PN and PM~10~ exposure. [@r26] and [@r22] found associations with thrombus formation and platelet function 2 and 6 hr after exposure, respectively. These end points may be more specific for determination of acute coagulatory effects ([@r7]).

*Sensitivity and subgroup analyses.* The mean post exposure -- preexposure exposure difference was different for cycling trips and car/bus trips for leukocytes, neutrophils, APTT, PT, IL10, and TNFα. This could be a result of the higher level of exercise during cycling. Strenuous exercise acutely affects white cell count ([@r24]), coagulation markers ([@r46]), and inflammation markers ([@r15]; [@r24]); moderate exercise during cycling may also influence these markers. Because we adjusted for trip type and because exercise levels were constant from day to day, these two factors have not affected the observed associations between air pollution and these end points. In a previous article describing respiratory end points in this population ([@r50]), we reported small associations of PN and soot with peak flow and airway resistance, but not with exhaled NO, a marker of airway inflammation. However, we did report a positive association with exhaled NO in the car/bus trips ([@r50]). In line with this, in the present study, the marker of systemic inflammation IL10 was not associated with air pollutants in the full population, but there was a positive but nonsignificant association with IL10 and soot exposure (*p* = 0.08) and soot dose (*p* = 0.08) in car/bus trips.

In the present study, we dealt with the influence of other factors, such as age, sex, obesity, and diet, on associations between air pollution and blood markers by looking at changes in markers between postexposure and preexposure values and by including random intercepts for subjects. We eliminated effects of circadian variation in blood markers by drawing the blood samples at the same time on each test day.

*Strengths and limitations.* In-vehicle studies provide a good opportunity to study associations between short-term air pollution exposure and acute health effects ([@r2]). Studies of ambient air pollution face problems in exposure misclassification, but we obtained precise information on exposure of the participants. We corrected for the influence of prior ambient exposure by adjusting for levels of ambient air pollution of the day before. In controlled exposure studies, subjects are exposed to a mixture of pollutants that may be less representative of outdoor situations. We studied real-life exposure, on a route and in modes of transport that are representative of Dutch commutes. Our study included a large number of observations, leading to precise effect estimates, especially for coagulation markers and blood cell counts. The large number of exposure days resulted in a wide range in air pollution levels, sufficient to study the relation between air pollution and health effects. Correlations between air pollutant exposures were low to moderate, facilitating analyses of the separate effects of PN and PM~10~ on health outcomes. PN exposures during cycling were characterized by many high, short peaks, whereas exposures during car/bus trips were characterized by fewer and lower peaks of longer duration. There was no indication that associations with 95th percentile values were stronger than with mean or median values (data not shown). Inhalation rates were estimated using heart rates, giving valuable information on inhaled doses that were of specific importance because of the comparison of cycling trips with car/bus trips. We did not find stronger associations for doses compared with exposures.

We may not have been able to observe associations because of the study design, study population, exposure issues, or timing of the health measurements. Our study derived exposure contrast from day-to-day variation in air pollution and differences between modes of transport. Other studies have successfully used a control exposure using filtered air in a laboratory setting ([@r23]), with the disadvantage that other factors in a laboratory setting (e.g., temperature, relative humidity) also differ from ambient air exposures. PN within our study ranged from a few thousand to 80,000 particles/cm^3^, which is larger than the range reported by Jacobs et al. (maximum PN 40,000 particles/cm³ versus close to zero in the laboratory). Using masks with filters as controlled exposure was not feasible during bus and cycle trips.

Our study population consisted of healthy, middle-aged adults. Effects on cardiovascular parameters have been found to be more pronounced in susceptible subgroups such as subjects with cardiovascular disease, obesity or high BMI, diabetes, and elderly ([@r7]; [@r14]; [@r20]; [@r39]). Associations in our study were not different for subjects with high BMI than for subjects with low BMI (above or below 25 kg/m²) or for subjects with high or low fruit and vitamin intake.

We measured blood markers only 6 hr after exposure; therefore, we may have missed immediate and more delayed responses. There is evidence from previous studies ([@r18]; [@r26]; [@r27]; [@r42]) that neutrophils, CRP, and platelets may be affected within 6 hr after exposure. Concurrent-day ambient exposure was associated with increases in CRP ([@r34]; [@r36]) and fibrinogen ([@r31]), but these studies do not allow more detailed definition of time windows of response. Several controlled exposure studies have reported airway inflammation at 4--6 hr after exposure ([@r42]; [@r45]), which may lead to systemic inflammation ([@r7]).

We conclude that air pollution exposure during commuting was not consistently associated with acute changes in inflammation markers, blood cell counts, or blood coagulation markers.
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=====================
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